MBRX
Moleculin BiotechยทNASDAQ
--
--(--)
--
--(--)
MBRX fundamentals
Moleculin Biotech (MBRX) released its earnings on Aug 12, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.49 (YoY +71.18%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.49
+71.18%
Report date
Aug 12, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Moleculin Biotech (MBRX) key financial stats and ratios, covering profitability, financial health, and leverage.
Moleculin Biotech (MBRX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Moleculin Biotech (MBRX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Moleculin Biotech (MBRX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Moleculin Biotech (MBRX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Moleculin Biotech (MBRX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Moleculin Biotech's management provide for the next earnings period?What does Moleculin Biotech do and what are its main business segments?What factors drove the changes in Moleculin Biotech's revenue and profit?What is Moleculin Biotech's latest dividend and current dividend yield?What is Moleculin Biotech's gross profit margin?What is the market's earnings forecast for Moleculin Biotech next quarter?What is the revenue and EPS growth rate for Moleculin Biotech year over year?Did Moleculin Biotech beat or miss consensus estimates last quarter?
